British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco is being sued in London by over 100 current and former shareholders, who allege the company didn’t fully disclose U.S. sanctions breaches tied to its North Korea operations. The group lodged their claim at London’s High Court on Feb. 27, according to the claimants’ legal team.

British American Tobacco shares ticked up 0.2% to 4,483 pence by 0914 GMT in London’s early session on Friday, adding to Thursday’s gains. Investors parsed a new buyback announcement and comments from management regarding growth targets for 2026.

By 0851 GMT on Tuesday, British American Tobacco dipped 0.4% to 4,438 pence, having earlier bounced between 4,450 and 4,388 pence.

British American Tobacco repurchased 117,545 shares on Tuesday under its ongoing buyback programme, paying a volume-weighted average price of 4,475.9562 pence per share—a figure that factors in the number of shares traded at each price. The company intends to cancel these shares, which will leave 2,176,662,435 shares outstanding after the cancellation, not counting treasury shares.

British American Tobacco shares held steady in early Monday trading following a routine filing that revealed another tranche of share buybacks under its existing programme. By 0820 GMT, the stock inched up 1 pence to 4,327 pence, after finishing at 4,326 pence on Friday.

British American Tobacco shares slipped 0.3% to finish at 4,326 pence on Friday in London.